Home / News Update  / Maturity of hearing healthcare ecosystem is counterbalanced by the increasing number of hearing disorders

Maturity of hearing healthcare ecosystem is counterbalanced by the increasing number of hearing disorders

Not so long ago, hearing disorder was neglected as an ailment in our country. Fortunately, the tides have turned today, as more and more people in India are earning disposable incomes. But the maturity of

Not so long ago, hearing disorder was neglected as an ailment in our country. Fortunately, the tides have turned today, as more and more people in India are earning disposable incomes. But the maturity of hearing healthcare ecosystem is counterbalanced by the increasing number of hearing disorders caused by the seismic lifestyle changes, wherein the number of births with disorders is also on the rise.
Thankfully, the government has been proactively running hearing screening programs since 2011, which test the hearing ability of a new-born in the hospital itself and refer them to appropriate practitioners in case of an anomaly. The large number of devices it has been procuring to commence the early intervention centres has been nurturing the growth of the hearing healthcare device industry. Sure! The demand for hearing screening, diagnostic and therapeutic devices has hit an all-time high. However, except for basic Audiometers; all the hearing screening and diagnostic products are imported into India, since the market is controlled by three major group companies under different brand name based out of Europe and U.S. And the Indian companies manufacturing only the basic Audiometers are into a price
war, as opposed to shedding spotlight on the product’s quality or customer requirements. Hence, people have no choice but to purchase either an imported device sold at exorbitantly high prices or the low quality local product. Amidst them, Labat Asia Private Limited is a forward looking company that is leveraging path breaking technologies bringing innovations in an industry that is long-over-due for a
revolutionary product line which is of excellent quality yet affordable to the masses.

KEY MANAGEMENT
TARLOCHAN DEV, FOUND & MANGING DIRECTOR
A SELF-MOTIVATED, RESPONSIBLE, HARD WORKING, EXTREMELY POSITIVE AND HONEST INDIVIDUAL, TARLOCHAN DEV IS THE DRIVING FORCE PROPELLING LABAT ASIA TO GREATER HEIGHTS WITH HIS BUSINESS DEVELOPMENT &
CUSTOMER RELATIONSHIP BUILDING EXPERTISE, A FIRST GENERATION ENTREPRENEUR WITH NEARLY FOUR DECADES OF EXPERIENCE IN THE HEALTHCARE & MEDICAL EQUIPMENT INDUSTRY, HE IS ONE OF THE SELECT FEW
WITH A TRUE GRASP OF THE FUNDAMENTALS OF THE INDUSTRY. WITH DEEP LOVE TOWARDS MOTHER NATURE, HE PROTECTS THE ENVIRONMENT, PLANTS TREES, RUNS TREE PLANTATION DRIVES, ORGANISES BLOOD DONATION CAMPS,
AND EVEN MOTIVATES PEOPLE AROUND TO KEEP PHYSICALLY & MENTALLY FIT. HE ALSO MENTORS OTHER MEDICAL EQUIPMENT COMPANIES IN THE AREA AND MOTIVATES AND EVEN HAND-HOLDING THEM TO FOSTER MAKE-IN-INDIA
CAMPAIGN.

AWARDS:
„BEST EMERGING MEDICAL EQUIPMENT COMPANY IN PUNJAB‟ BY TIMES
CYBERMEDIA GROUP 2018.
Emerging into the Country‟s First One-Stop-Shop

14th MT INDIA HEALTHCARE AWARD conferred by Medgate today Magazine Most promising company in MAKE in India Initiative 2024
Labat Asia was incepted in 2010 by Tarlochan Dev (Founder & Managing Director) as a Joint Venture with Labat International Italy, as a trading company importing fully furnished goods. Despite being a pioneer in introducing PC based hearing solutions since 1998, due to its smaller size (vis-à-vis the behemoths ruling the market), Labat Italy wasn’t able to reach the huge number of audience it deserved
and had a very limited product range:
When Labat Asia was launched; Tarlochan realized that in order to remain technically competitive, the company must start producing goods missing from Labat’s portfolio (Including good quality entry level Audiometers), and also enhance its existing range. As a result, Labat Asia kick started its own in-house R&D department in 2012 to develop & manufacturer these import substitute products. “The objective is
to save our country’s valuable foreign exchange by providing local solutions of the international standards and earing foreign exchange for the country by exporting these products to rest of the world.

Labat Asia; today, is 100% Indian company and manufacturing range of Audiometers, Auditory Evoked Potentials and now launching in June 2024, the much awaited and much needed product Tympanometer. We aspire to be a one-stop-shop for any hearing screening/hearing diagnostic products,” asserts Tarlochan. The company has a state of the art manufacturing facility situated in Mohali in the Chandigarh Tricity (India) of truly international standard. It has implemented ISO 13485 and has a valid manufacturing License from its regulator, CDSCO. Its products are tested for electrical safety i.e. IEC 60601 from NABL accredited labs. All this is done with the sole objective and vision of Make in India and Made for
the World.

His goal sounds even more ambitious considering the fact that only a handful of manufacturers worldwide are into this product line. “Our entry-level Screening & Clinical audiometers are very much comparable with any international Audiometers, but made available at much lesser cost than the imported ones, but for much more than the average India range,” divulges Tarlochan. The heavy investments it had been pouring on its R&D since 2012 came into fruition by end of 2016, giving it indigenously developed products. Embarked on this new avatar with a much needed totally new software for the Italian Diagnostic Audiometer, Labat Asia introduced its own Free Field Audiometer &
Visual Reinforced Audiometers in the same year, followed by the production of Screening & Clinical Audiometers in 2018. In fact, its recently launched Diagnostic Audiometer developed with the cuttingedge technology has much more advanced features than the Italian make. Today, standing tall as an affluent manufacturer, importer and exporter of a wide array of hearing screening & hearing diagnostic
equipment, Labat exports its products to the countries of UAE, Malaysia, Indonesia, Singapore, Bangladesh, Nepal & Vietnam as well and soon entering some large markets.

The Indomitable Team

These accomplishments are made possible by its R&D department consisting of B.Tech & M.Tech engineers, who are spearheaded over 30 years of experience from all around the world (U.S., Singapore, Israel and Japan). Labat Asia has its own building (Approximately 8000 sq.ft. and has an expansion scope for another 1500sq.ft.) , which house a well-laid training hall and a growing team of 45+ peoples
spread across departments of commercial support, Export, Accounts, Customer Support, Sales Support, HRD, Production, Service & Calibration, Supply Chain & Purchase and R&D.

The Noble Roadmap
Labat Asia also intends to contribute towards better environment and it is taking lot of steps for a greener tomorrow. One of them is to cut down on the travel. We have a YouTube channel and already made many educational videos for Installation, demonstration, operational training and Maintenance videos which helped reduce the travelling by about 80%. By reducing travelling we are not cutting down
costs but also reducing carbon foot prints and contributing towards better environment. Labat has also implemented some measures in its infrastructure which help cut down on carbon footprints. All our devices, appliances and light fittings etc are energy efficient. The building layout is designed in a way where every seat gets full daylight and hardly need any electrical lighting except for in winters or rainy season. It also has a proper ventilation system to cut down on the Air-conditioning energy. All these cost saving measures result in ensuring an economical price tag for its products, thereby making the hearing healthcare more affordable. With such a noble roadmap, Labat Asia seems set to make a huge positive impact and place India on the global map for the complete range of high caliber hearing diagnostic products.

“OUR PRODUCTS ARE VERY MUCH COMPARABLE WITH ANY INTERNATIONAL PRODUCTS, BUT MADE AVAILABLE AT A MUCH LESSER COST THAN THE IMPORTED ONES”

medgatetoday@gmail.com

Review overview
NO COMMENTS

POST A COMMENT